mella

  1. M

    B-Lymphocyte Depletion in Patients With ME/cfs: A Randomized, Double-Blind, Placebo-Controlled Trial (2019) Fluge et al

    B-Lymphocyte Depletion in Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial https://annals.org/aim/article-abstract/2729813/b-lymphocyte-depletion-patients-myalgic-encephalomyelitis-chronic-fatigue-syndrome-randomized...
  2. Kalliope

    Clinical Therapeutics: Rituximab Serum Concentrations and Anti-Rituximab Antibodies During B-Cell Depletion Therapy for CFS/ME - Rekeland,Mella et al

    Rituximab Serum Concentrations and Anti- Rituximab Antibodies During B-Cell Depletion Therapy for Myalgic Encephalopathy/Chronic Fatigue Syndrome Rekeland, Fluge, Mella et al (only the abstract is available for now) Findings There were no significant differences in mean serum rituximab...
  3. Kalliope

    Prof. Mella - Autoimmunity and metabolism in ME/CFS (lecture)

    Here is a lecture from prof. Olav Mella from a conference in Oslo November 2017. Language: Norwegian Subtitles: English Duration: 26 minutes
  4. Kalliope

    Research Conference in Oslo 20-21 nov with Davis, Hornig & Mella

    Research Conference in Oslo 20 - 21. November 2017 The Norwegian ME Association is preparing a research conference in cooperation with Oslo university Hospital and the Norwegian Institute of public Health. The first day is for researchers only, primarily from Scandinavia. The second day has an...
  5. adreno

    Metabolic profiling indicates impaired pyruvate dehydrogenase function in ME/CFS, 2016, Fluge, Mella et al

    Another important one: https://insight.jci.org/articles/view/89376
  6. Cheshire

    Øystein Fluge and Olav Mella's ME/CFS research

    Rituximab (RituxME) Clinical impact of B-cell depletion with the anti-CD20 antibody rituximab in chronic fatigue syndrome: a preliminary case series Øystein Fluge and Olav Mella BMC Neurology 2009 Link to article Benefit from B-Lymphocyte Depletion Using the Anti-CD20 Antibody Rituximab in...
Back
Top Bottom